Premium
Clinical pharmacology in the United Kingdom
Author(s) -
Smith Robert N.
Publication year - 1974
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1974163part2605
Subject(s) - clinical pharmacology , pharmaceutical industry , medicine , safety pharmacology , pharmacology , legislation , food and drug administration , drug , political science , law
The impetus for the establishment of academic clinical pharmacology units in the United Kingdom has often originated from concern regarding the teaching of pharmacology, and because of the unavailability of sufficient, trained personnel, and individual academic unit often centered around the interests of one pharmacologically oriented investigator. While industry had initiated clinical pharmacology independently, the thalidomide disaster with its resultant governmental legislation markedly accelerated the development of the field u;ithin the pharmaceutical industry. Although the workload upon the Committee for the Safety of Medicines (CSM) has increased currently with a resultant increase in the “process time,” the CSM, by utilizing a flexible and realistic attitude, has managed to avoid many of the problems the Food and Drug Administration (FDA) in the United States has encountered.